Codelac Broncho pill 20 pcs
Condition: New product
997 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Ambroxol + Sodium glycyrrhizinate + Thyme creeping herb extract
Release form
Pills
Composition
Active ingredient: Ambroxol hydrochloride (Ambroxol) + sodium glycyrrhizinate (Sodium glycyrrhzinate) + sodium bicarbonate (Sodium hydrocarbonate) Active ingredient concentration (mg): Ambroxol hydrochloride (Ambroxol) 20 mg, glycinyrrhizinic acid sodium salt (sodium sodium (glycidyrrhizinate) (Ambroxol) 20 mg, glycerrhizinic acid sodium salt (glycerrhizinic acid hydrochloride (Ambroxol) 20 mg), sodium glycinyrrhizinic acid (mg sodium chloride) (sodium glucic rhizinate hydrochloride (Ambroxol) 20 mg; dry 10 mg, sodium bicarbonate 200 mg
Pharmacological effect
The combined drug for the treatment of cough, has mucolytic and expectorant effects, and also has anti-inflammatory activity. The action of Codelac Broncho is due to the pharmacological properties of its components. Ambroxol has a secretory-motor, secretolytic and expectorant effect, normalizes the disturbed ratio of serous and mucous components of sputum, increases the secretion of surfactant in the alveoli. It reduces the viscosity of sputum and promotes its discharge. Glycyrrhate (glycyrrhizic acid and its salts) has an anti-inflammatory and antiviral effect. It has a cytoprotective effect due to antioxidant and membrane stabilizing activity. Potentiates the action of endogenous corticosteroids, providing anti-inflammatory and anti-allergic effect. Due to pronounced anti-inflammatory activity, it helps to reduce the inflammatory process in the respiratory tract. Thermopsis extract has an expectorant effect, providing a moderate irritant effect on the receptors of the gastric mucosa, reflexively increases the secretion of bronchial glands. Sodium bicarbonate shifts the pH of bronchial mucus to the alkaline side, reduces viscosity of mucus, motor function of ciliated epithelium and bronchioles.
Pharmacokinetics
Data on the pharmacokinetics of the drug Codelac Broncho are not provided.
Indications
Diseases of the respiratory tract with sputum obstruction: acute and chronic bronchitis, pneumonia, chronic obstructive pulmonary disease (COPD), bronchiectasis.
Contraindications
Hypersensitivity to the components of the drug, pregnancy, lactation, children under 12 years.
Precautionary measures
Do not exceed the recommended dose. It should be used with caution in patients with hepatic and / or renal failure, gastric ulcer and duodenal ulcer, with bronchial asthma.
Use during pregnancy and lactation
The drug Codelac Broncho is contraindicated during pregnancy and lactation (breastfeeding).
Dosage and administration
Inside, during the meal. Adults and children over 12 years old 1 tablet 3 times a day. It is not recommended to use without a medical appointment for more than 4-5 days
Side effects
Allergic reactions, weakness, headache, diarrhea, dry mouth and respiratory tract, exanthema, rhinorrhea, constipation, dysuria. With long-term use in high doses - gastralgia, nausea, vomiting.
Overdose
Symptoms: nausea, vomiting, diarrhea, dyspepsia. Treatment: gastric lavage is advisable in the first 1-2 hours after taking the drug; conducting symptomatic therapy.
Interaction with other drugs
Combined use with antitussive drugs leads to difficulty in sputum discharge on the background of cough reduction. The drug increases the penetration into the bronchial secret of antibiotics.
special instructions
Do not combine with antitussives.